Mylan Sulfamylon burn antimicrobial slated for advisory committee review, company says.
Executive Summary
MYLAN SULFAMYLON BURN ANTIMICROBIAL WILL GET ADVISORY CMTE. REVIEW on July 24, Mylan VP-Investor/Public Relations Patricia Sunseri indicated during the Dillon Read generic drug/delivery systems conference in New York City May 7. FDA's Anti-Infective Drugs Advisory Committee has a tentatively scheduled meeting set for July 24-26.